Matthias Alder's Net Worth
$1.25 Million
Who is Matthias Alder?
Matthias Alder has an estimated net worth of $1.25 Million. This is based on reported shares across multiple companies, which include Sucampo Pharmaceuticals, Inc., Gain Therapeutics, Inc., and MICROMET, INC..
SEC CIK
Matthias Alder's CIK is 0001370820
Past Insider Trading and Trends
2016 was Matthias Alder's most active year for acquiring shares with 8 total transactions. Matthias Alder's most active month to acquire stocks was the month of February. 2012 was Matthias Alder's most active year for disposing of shares, totalling 8 transactions. Matthias Alder's most active month to dispose stocks was the month of February. 2021 saw Matthias Alder paying a total of $1,172,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2012 Matthias Alder cashed out on 683,304 shares for a total of $4,517,793.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sucampo Pharmaceuticals, Inc. No price found
EVP, Gen. Council & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.45% | 673 |
$8.93 | $6,009.89 | 4.76K |
Jun 30
| |||
Form 4
| +17.89% | 641 |
$9.35 | $5,993.35 | 4.22K |
Mar 31
| |||
Form 4
|
∞
| 33K |
—
|
—
| 33K |
Mar 6
| |||
Form 4
| +3.89% | 134 |
$10.46 | $1,401.64 | 3.58K |
Dec 31
| |||
Form 4
|
—
|
0
|
$12.17 | -$1,150,868.75 | 3.45K |
Nov 23 - Nov 28
| |||
Form 4
| +22.74% | 639 |
$9.38 | $5,993.82 | 3.45K |
Sep 30
| |||
Form 4
| +36.54% | 752 |
$9.32 | $7,008.64 | 2.81K |
Jun 30
| |||
Form 4
| +45.65% | 645 |
$9.29 | $5,992.05 | 2.06K |
Mar 31
| |||
Form 4
| +50.96% | 477 |
$14.70 | $7,011.90 | 1.41K |
Dec 31 - Mar 2
| |||
Form 4
|
∞
| 936 |
$13.88 | $12,989.27 | 936 |
Jun 30 - Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gain Therapeutics, Inc. (GANX) Snapshot price: $4.7603
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +201.44% | 14.13K |
$4.06 | -$24,705.10 | 21.14K |
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +8.88% | 431 |
$2.46 | -$506.76 | 5.29K |
Dec 20 - Dec 21
| |||
Form 4
| -27.27% | -1.82K |
$2.50 | -$4,550.00 | 4.86K |
Dec 7
| |||
Form 4
| +14.10% | 825 |
—
|
—
| 6.67K |
Oct 1
| |||
Form 4
| +77.27% | 2.55K |
—
|
—
| 5.85K |
Sep 20
| |||
Form 4
|
∞
| 3.3K |
—
|
—
| 3.3K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MICROMET, INC. No price found
SVP, GC and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
$5.00 | -$65,037.00 |
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
$4.46 | -$54,069.00 |
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||